New screening methods that can add predictive diagnostic value for aggressive (high-grade, Gleason score greater than or equal to7) prostate cancer (PCa) are needed to reduce unnecessary biopsies for patients with non-aggressive PCa. This is particularly important for men presenting ...
Read More »